Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Xeljanz Safety Alert for People Who Are (1) Older, (2) Current / Past Smokers, or (3) With Cardiovascular or Cancer Risk Factors

January 21, 2022 By Law Offices of Thomas J. Lamb, P.A.

This excerpt from the “Advisory – Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer” issued in January 2022 provides an overview of the Xeljanz drug safety issue, and how the Xeljanz side effects risks may also apply to Olumiant and … [Read more...]

Filed Under: Unsafe Drugs Tagged With: cancers, cardiovascular events, heart problems, lung cancer, lymphoma, Myocardial Infarction, Olumiant, Rinvoq, Xeljanz

Philips Bi-Level PAP, CPAP, and Mechanical Ventilators Part of Products Recall in June 2021

June 24, 2021 By Law Offices of Thomas J. Lamb, P.A.

In connection with a June 2021 Philips products recall, our law firm is investigating possible lawsuits against Philips for patients who have developed cancer or experienced organ failure following toxic exposures from the polyester-based polyurethane (PE-PUR) sound abatement foam component in these recalled Philips products: Philips … [Read more...]

Filed Under: Unsafe Medical Devices Tagged With: Kidney cancer, Kidney Failure, Liver Cancer, liver failure, lung cancer, Philips Bi-Level PAP, Philips Bi-Level Positive Airway Pressure, Philips Continuous Positive Airway Pressure, Philips CPAP, Philips Mechanical Ventilators, Products Recall

Environmental exposure to asbestos and the risk of lung cancer: a systematic review and meta-analysis

June 10, 2021 By Law Offices of Thomas J. Lamb, P.A.

Asbestos is a carcinogen associated with lung cancer, but few studies have examined the increased risk of lung cancer due to environmental asbestos exposure. We performed a systematic review and meta-analysis to evaluate the association between environmental asbestos exposure and lung cancer. We searched for articles on non-occupational or … [Read more...]

Filed Under: Asbestos Tagged With: asbestos, asbestos cancer, asbestos exposure, lung cancer

There Will Be No Belviq Generic Drugs After Belviq Drug Recall in 2020

April 13, 2021 By Law Offices of Thomas J. Lamb, P.A.

There has been some further FDA action regarding Belviq which is related to the 2020 Belviq drug recall that was due to an increased risk of cancer. This further FDA action means there will be no Belviq generic drugs after the Belviq drug recall in 2020. This February 26, 2021 Notice item, “Determination That BELVIQ (Lorcaserin Hydrochloride) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, Colorectal Cancer, lung cancer, Pancreatic Cancer, Rectal cancer

What is the link between asbestos and lung cancer?

March 17, 2021 By Law Offices of Thomas J. Lamb, P.A.

Asbestos is a material that people have used as insulation since the Industrial Revolution. There are strong associations between asbestos and certain types of cancer, including lung cancer and mesothelioma, which is a type of cancer that affects the mesothelial cells. According to the American Cancer Society, several expert agencies, including … [Read more...]

Filed Under: Asbestos Tagged With: asbestos, asbestos exposure, lung cancer

FDA Belviq Recall Decision Came After Safety Data Review Found Excess Cancers Risks

September 22, 2020 By Law Offices of Thomas J. Lamb, P.A.

In this FDA staff article, “Cancer risk associated with lorcaserin — The FDA’s review of the CAMELLIA-TIMI 61 trial”, which was published by the New England Journal of Medicine (NEJM), the early 2020 FDA Belviq recall decision was explained. Essentially, this FDA action after a careful analysis of Belviq safety data that revealed excess … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, leukemia, lung cancer, Pancreatic Cancer, Rectal cancer

Private Settlement Reached in Mesothelioma Case

July 30, 2020 By Law Offices of Thomas J. Lamb, P.A.

A private settlement was reached in a mass litigation asbestos case [on July 28, 2020] in Ohio County [(West Virginia)] Circuit Court, meaning a trial set to take place at The Highlands Event Center next week won’t be necessary. Both Ohio County Clerk of Courts Brenda Miller and court employees for Judge Ronald Wilson said details of the … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos, asbestos lawsuits, lung cancer, mesothelioma, mesothelioma lawsuits

After Drug Recall Belviq Lawsuits Alleging Failure To Warn About Cancer

May 21, 2020 By Law Offices of Thomas J. Lamb, P.A.

Following the Belviq recall in February 2020 some of those patients on Belviq developing cancer filed Belviq lawsuits alleging a failure to warn about the risk of cancer associated with Belviq. We are investigating possible Belviq lawsuits that involve patients on Belviq developing cancer. At the present time, our focus for these Belviq lawsuits … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, lung cancer, Pancreatic Cancer, Rectal cancer

EPA finds asbestos poses cancer risks for workers, reigniting calls for ban

April 10, 2020 By Law Offices of Thomas J. Lamb, P.A.

The Environmental Protection Agency (EPA) has determined that [ asbestos dust ] poses an unreasonable risk of [ lung cancer and mesothelioma ] to both workers and consumers who inhale it, ramping up pressure on the agency to ban the substance. In a draft risk assessment published this week, the EPA said that workers who inhale [ asbestos dust ] … [Read more...]

Filed Under: Asbestos Tagged With: asbestos, asbestos cancer, asbestos exposure, asbestos-related disease, lung cancer, mesothelioma

Belviq Recall Due To Certain Cancers: Pancreatic, Colon, Rectal, And Lung

February 18, 2020 By Law Offices of Thomas J. Lamb, P.A.

The diet drug Belviq is being withdrawn from the US market because a Belviq safety clinical trial shows an increased occurrence of cancer cases. This February 2020 Belviq FDA Drug Safety Communication announced the Belviq recall, “FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market”, and noted that … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, lung cancer, Pancreatic Cancer, Rectal cancer

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.